Synthesis of duloxetine and its pharmaceutically acceptable salts by using the procedure of asymmetric transfer hydrogenation
SI22571A
Stable solid pharmaceutical preparation which includes candesartan orits pharmaceutically acceptable forms
SI22572A
Stable solid pharmaceutical composition which comprises candesartan or its pharmaceutically acceptable forms
SI22585A
Procedure for preparation of telmisartan
DE102004060412A1
New isopropanol and water mixed solvate of olanzapine used to prepare any other solvate and/or hydrate forms of olanzapine, or anhydrous forms of olanzapine
Solid composition used as acetyl cholinesterase inhibitor comprises perindopril, microcrystalline cellulose, inorganic carbonate and other components
SI21746A
Crystal forms of olanzapine and processes for their preparation
DE102004005186B3
Process for the preparation of purified ciprofloxacin
DE102004005009A1
Delayed release pharmaceutical composition of indapamide
DE10359154A1
Process for the preparation of venlafaxine and venlafaxine hydrochloride Form I
DE10337773A1
Crystallization of solid forms of clopidogrel addition salts
DE10333497A1
Sustained release composition useful in the treatment of e.g. benign prostatic hyperplasia comprises Tamsulosin core with a coating containing combination of polyvinyl acetate and polyvinyl pyrrolidone
DE10329812A1
Sustained release composition useful in the treatment of e.g. benign prostatic hyperplasia comprises Tamsulosin core with a coating containing combination of polyvinyl acetate and polyvinyl pyrrolidone
DE10301923B3
Process and intermediates for the production of olanzapine
SI9800057A
Process for production of simvastatine and its derivatives
